Regulation of SET Gene Expression by NFkB

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Neurobiology

• Publication date

  2016-06-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-016-9967-2PMID 27351675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The N-terminal Set-β Protein Isoform Induces Neuronal Death*

  2015cited by this paper
• SET translocation is associated with increase in caspase cleaved amyloid precursor protein in CA1 of Alzheimer and Down syndrome patients.

  2014cited by this paper
• Upregulation of SET Expression by BACE1 and its Implications in Down Syndrome

  2014cited by this paper
• Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau*

  2014cited by this paper
• Transcriptional regulation of human USP24 gene expression by NF‐kappa B

  2014cited by this paper
• Upregulation of human PINK1 gene expression by NFκB signalling

  2014cited by this paper
• Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.

  2013cited by this paper
• Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.

  2013cited by this paper
• Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.

  2012cited by this paper
• Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease

  2012cited by this paper
• NF‐κB signaling inhibits ubiquitin carboxyl‐terminal hydrolase L1 gene expression

  2011cited by this paper
• Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2 PP2A/SET

  2011cited by this paper
• The carboxy‐terminal fragment of inhibitor‐2 of protein phosphatase‐2A induces Alzheimer disease pathology and cognitive impairment

  2010cited by this paper
• Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

  2009cited by this paper
• Sp1-mediated transcription regulation of TAF-Ialpha gene encoding a histone chaperone.

  2008cited by this paper
• The nuclear localization of SET mediated by impalpha3/impbeta attenuates its cytosolic toxicity in neurons.

  2007cited by this paper
• Relationship between the structure of SET/TAF-Iβ/INHAT and its histone chaperone activity

  2007cited by this paper
• The nuclear localization of SET mediated by impα3/impβ attenuates its cytosolic toxicity in neurons

  2007cited by this paper
• Histone acetylation-independent transcription stimulation by a histone chaperone

  2006cited by this paper
• Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease.

  2005cited by this paper
• Immortalized fibroblasts from NF-κB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor α after transformation by v-Ras

  2005cited by this paper
• SET protein (TAF1β, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain

  2005cited by this paper
• Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation

  2005cited by this paper
• Positive and Negative Regulation of the Cardiovascular Transcription Factor KLF5 by p300 and the Oncogenic Regulator SET through Interaction and Acetylation on the DNA-Binding Domain

  2003cited by this paper
• Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A

  2003cited by this paper
• The Identification and Characterization of Oxidized RNAs in Alzheimer's Disease

  2003cited by this paper
• Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.

  2001cited by this paper
• Protein oxidation in the brain in Alzheimer's disease.

  2001cited by this paper
• Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis.

  2000cited by this paper
• Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

  1998cited by this paper
• Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor.

  1998cited by this paper
• Cellular localization and expression of template-activating factor I in different cell types.

  1998cited by this paper
• New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry

  1998cited by this paper
• The Myeloid Leukemia-associated Protein SET Is a Potent Inhibitor of Protein Phosphatase 2A (*)

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delay

  1996cited by this paper
• Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.

  1995cited by this paper
• Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

  1995cited by this paper
• Spatially restricted expression of set mRNA in developing rat kidney.

  1994cited by this paper
• Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene

  1992cited by this paper

• Cannabidiol improves cognitive impairment after traumatic brain injury by attenuating neuronal oxidative stress and apoptosis via the SET/PP2A/Akt signaling axis.

  2026cites this paper
• Pathological tau activates inflammatory nuclear factor-kappa B (NF-κB) and pT181-Qβ vaccine attenuates NF-κB in PS19 tauopathy mice

  2025cites this paper
• Common Signaling Pathways in Cancer and Alzheimer's Disease May Point to New Treatments.

  2025cites this paper
• Unveiling the Therapeutic Potential of Kelulut (Stingless Bee) Honey in Alzheimer’s Disease: Findings from a Rat Model Study

  2024cites this paper
• Exploring the Therapeutic Potential of Glycyrrhiza Compounds in Alzheimer's Disease: A Comprehensive Review.

  2024cites this paper
• Relationship between the cGAS-STING and NF-κB pathways-role in neurotoxicity.

  2024cites this paper
• Endoplasmic reticulum stress and related diseases

  2024cites this paper
• The complex effects of miR-146a in the pathogenesis of Alzheimer’s disease

  2024cites this paper
• The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation

  2023influential citation
• The next decade of SET: from an oncoprotein to beyond

  2023cites this paper
• Potential of hsa-miR200a-3p and hsa-miR502-3p as blood-based biomarker for Alzheimer’s disease

  2022cites this paper
• Exposure to a mixture of heavy metals induces cognitive impairment: genes and microRNAs involved.

  2022cites this paper
• Paraquat Induces Lung Injury via miR-199-Mediated SET in a Mouse Model

  2022cites this paper
• The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease

  2022cites this paper
• Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: the role of TNF-α/NF-κB/IL-1β axis inhibition

  2022cites this paper
• Deep Neural Network Classifier for Alzheimer’s Disease

  2022cites this paper
• Effect of Garcinia mangostana pericarp extract on glial NF-κB levels and expression of serum inflammation markers in an obese-type 2 diabetes mellitus animal model

  2021cites this paper
• Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases

  2020cites this paper
• Cyclin-dependent kinase 1-mediated phosphorylation of SET at serine 7 is essential for its oncogenic activity

  2019cites this paper
• Fluoride Exposure Induces Inhibition of Sodium-and Potassium-Activated Adenosine Triphosphatase (Na+, K+-ATPase) Enzyme Activity: Molecular Mechanisms and Implications for Public Health

  2019cites this paper
• The Contribution of Fluoride to the Pathogenesis of Eye Diseases: Molecular Mechanisms and Implications for Public Health

  2019cites this paper
• Transcriptional activation of USP16 gene expression by NFκB signaling

  2019cites this paper
• Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease

  2019cites this paper
• A comprehensive and perspective view of oncoprotein SET in cancer

  2018cites this paper
• Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans

  2017cites this paper
• Zinc Finger and X-Linked Factor (ZFX) Binds to Human SET Transcript 2 Promoter and Transactivates SET Expression

  2016cites this paper